|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||6.74 - 7.02|
|52 Week Range||1.40 - 12.30|
|PE Ratio (TTM)||482.14|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Unlike its southern neighbor, Canada legalized medical marijuana nationwide back in 2001. Further, Canada introduced the Cannabis Act recently and the bill to legalize recreational pot use is expected to pass by July of 2018. Not so in the U.S., where the immediate future for legal weed is in question, after Attorney General Jeff Sessions overturned an Obama-era law that protected states choosing to liberalize legal marijuana laws.
Terry Booth took the helm as Aurora Cannabis Inc’s (TSX:ACB) CEO and grew market cap to CA$4.84B recently. Understanding how CEOs are incentivised to run and grow their company isRead More...
Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture:RTI) is pleased to announce the following update on its operations and 2018 growth initiatives. Further to its news release of January 9, 2018, Radient has now signed a definitive share purchase agreement with the Amnor Group Inc. (formerly 1396730 Alberta Ltd.) (the “Vendor”) to acquire a 100% interest in 1631807 Alberta Ltd., a joint venture company (the “JV”), from the Vendor (the “JV Transaction”). The JV owns the land and building that contains the 20,000 square feet manufacturing facility in Edmonton, Canada (the “Facility”) operated by Radient.
Aurora Cannabis to Build "Aurora Sun", 1.2 Million Square Foot Facility in Medicine Hat, Alberta
Aurora Cannabis Gains Exclusive License to Novel Patented Sub-Lingual Wafer Technology from CTT Pharmaceutical
Aurora Cannabis (ACB) (ACBFF) has had a disappointing run so far this year, with the stock falling 32% YTD (year-to-date) to close at $8 Canadian on April 12, 2018. YTD, Horizons Marijuana Life Science ETF (HMMJ) has fallen 10.4%. As of April 12, 2018, the consensus mean rating for Aurora Cannabis is 2.3 with an overall “buy” recommendation.
Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:25 a.m. ET.
On April 11, Hydropothecary (HYYDF) stock surged 13.2% after it became the SAQ’s (Société des alcools du Québec) preferred non-medical cannabis supplier once non-medical cannabis becomes legal in Canada. The company’s press release stated that the agreement term extends to the first five years following legalization and has an option to extend for another year.
Aurora Cannabis Completes Agreement with the Société des Alcools du Québec to Supply Cannabis for Quebec Adult Consumer Market
Last week, in our series Cannabis Players and Their Business Combinations, we learned that some agribusiness companies (HMLSF), such as Aurora Cannabis (ACB) (ACBFF), Cronos Group (CRON), and MedReleaf (MEDFF), are extending their businesses via strategic partnerships.
In the week that ended on April 6, 2018, Beacon Securities analyst Vahan Ajamian upgraded cannabis stock Canopy Growth (WEED) to a “buy” from a “hold.” Ajamian also raised his target price to 37 Canadian dollars from 24.5 Canadian dollars.
Last week, the S&P 500 Index (SPY) ended up with a fall of 1.4%, and the TSX 300 Composite Index ended the week with a fall of nearly 1%.
Canadian cannabis producers have seen their stocks, on average, decline 39% from the peak three months ago, with several factors contributing to the decline.
Aurora Cannabis (ACB) (ACBFF), similar to Canopy Growth (WEED), has made several investments over the last two years. Aurora Cannabis has acquired approximately a one-fifth interest in Hempco for a supply of raw materials at low costs for CBD (cannabidiol) extraction. CBD is primarily used in medical cannabis products.
NEW YORK, NY / ACCESSWIRE / April 4, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...